Phreesia Reports Strong Fiscal 2025 Results

Phreesia ( (PHR) ) has released its Q4 earnings. Here is a breakdown of the information Phreesia presented to its investors.

Phreesia, Inc., a leader in patient activation solutions, provides digital tools for healthcare providers and life sciences companies to enhance patient engagement and improve healthcare outcomes. The company recently announced its financial results for the fourth quarter and fiscal year ending January 31, 2025, highlighting significant growth and strategic advancements.

In the fourth quarter, Phreesia reported a 15% year-over-year increase in total revenue, reaching $109.7 million. The average number of healthcare services clients rose by 10%, while total revenue per client increased by 5%. Notably, the company reduced its net loss to $6.4 million from $30.6 million in the previous year, and achieved a positive adjusted EBITDA of $16.4 million, a significant improvement from the negative $3.5 million reported last year.

For the fiscal year 2025, Phreesia’s revenue grew by 18% to $419.8 million, with a 17% increase in healthcare services clients. The company also reported a substantial reduction in net loss from $136.9 million in fiscal 2024 to $58.5 million in fiscal 2025. Adjusted EBITDA turned positive at $36.8 million, compared to a negative $35.4 million in the prior year. Additionally, Phreesia generated $32.4 million in net cash from operating activities, a significant turnaround from the $32.4 million used in the previous fiscal year.

Looking ahead, Phreesia maintains a positive outlook for fiscal 2026, expecting revenue to range between $472 million and $482 million, with adjusted EBITDA projected between $78 million and $88 million. The company anticipates continued growth in healthcare services clients and revenue per client, supported by its strong cash position and operational efficiency improvements.